Skip to content

The International Registry for Leigh Syndrome

The International Registry for Leigh Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03137355
Enrollment
200
Registered
2017-05-02
Start date
2015-06-17
Completion date
2030-06-17
Last updated
2023-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leigh Disease, Leigh's Necrotizing Encephalopathy, Leigh Syndrome, Subacute Necrotizing Encephalomyelopathy, Subacute Necrotizing Encephalomyopathy

Keywords

Leigh Syndrome, Leigh Disease, Leigh's Necrotizing Encephalopathy, Subacute Necrotizing Encephalomyelopathy, Subacute Necrotizing Encephalomyopathy

Brief summary

The purpose of this study is to develop a database containing clinical and laboratory information for patients with Leigh syndrome. The goal is to provide a greater understanding of Leigh syndrome allowing further characterization of this disease.

Detailed description

Leigh syndrome, also known as juvenile sub-acute necrotizing encephalopathy, is a progressive neurodegenerative disorder associated with dysfunction of mitochondrial oxidative phosphorylation (OXPHOS). First described in 1951 by British neuropsychiatrist Archibald Denis Leigh, the condition has evolved from a post mortem diagnosis to a clinical entity with characteristic radiologic and laboratory findings. Leigh syndrome is a rare and heterogeneous disease, finding a substantial number of patients to study is difficult. The lack of natural history data in Leigh syndrome and the small number of patients included in clinical reports thus far has limited the ability to fully comprehend the progression of this disease and assess prognostic factors. A Leigh syndrome database will help improve our understanding of this rare disease leading to an improved ability to predict outcomes and/or improve treatment paradigms. Collecting natural history data on Leigh syndrome and integrating this information into a database will be useful in understanding the course of the disease and identifying trends.

Interventions

None listed

Sponsors

The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
0 Days to 100 Years
Healthy volunteers
No

Inclusion criteria

* All participants with a diagnosis of Leigh syndrome will be invited to participate

Exclusion criteria

* People without Leigh syndrome

Design outcomes

Primary

MeasureTime frameDescription
Phenotypical characteristics of Leigh syndrome10 yearsThe goal of this project is to collect longitudinal data on the natural history of Leigh syndrome.

Countries

United States

Contacts

Primary ContactMary Kay Koenig, MD
leigh@uth.tmc.edu713-500-7164
Backup ContactWilliam Guerra
leigh@uth.tmc.edu713-500-7164

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026